advisorsecurities master

MDXGMiMedx Group, Inc

CSNasdaq (XNAS)·USD

Identity

Security key
18433
Ticker
MDXG
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2007-08-22
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
MDXG

Detail

Enriched 2026-08-14 20:47

Market cap
$623,854,803.04
Shares outstanding (class)
145,760,468
Shares outstanding (weighted)
145,760,468
SIC
3841 SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees
808
Location
MARIETTA, GA
Description

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data